IL-12 GENE THERAPY TO PRIME AND REPOLARIZE ANTI-TUMOR TH1-TYPE T CELLS
$196,095P01FY2009CANIH
University Of Pittsburgh At Pittsburgh, Pittsburgh PA
Investigators
Linked publications, trials & patents
Paper 22585706Paper 22552283Paper 22246626Paper 22215017Paper 22158522Paper 21995576Paper 21760628Paper 21189473Paper 20675595Paper 20549206Paper 19941313Paper 19915058Paper 19861464Paper 19752754Paper 19520829Paper 19444303Paper 19390568Paper 19348609Paper 19190335Paper 18829566Paper 18622355Paper 18566374Paper 18520636Paper 18405863Paper 18324354Paper 18250414Paper 18093336Paper 18023240Paper 17616706Paper 17344900Paper 17295916Paper 16740728Paper 16645618Paper 16618775
Abstract
University of Pittsburgh School of Medicine
View original record on NIH RePORTER →